Found 7 matching trials
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV
PHASE1Study objectives: To evaluate the immunogenicity and immunity persistence a...
Location
Zhejiang Provincial Center for Disease Control and Prevention
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac
PHASE1Study objectives: To evaluate the immunogenicity and immunity persistence a...
Location
Zhejiang Provincial Center for Disease Control and Prevention
ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization
PHASE1The purpose of this study is to evaluate the immunogenicity and safety of t...
Location
Hunan Provincial Center for Disease Control and Prevention
Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above
PHASE3A total of 1200 people aged 18 years and older who have completed two or th...
Location
Hubei Provincial Center for Disease Control and Prevention
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
PHASE3A randomized, double-blind, placebo-controlled international multicenter cl...
Location
Hunan Provincial Center for Disease Control and Prevention
ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization
PHASE1The purpose of this study is to evaluate the immunogenicity and safety of t...
Location
Hunan Provincial Center for Disease Control and Prevention Preventive Medicine Clinic
Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine
PHASE4This is a randomized, observer-blind, placebo-controlled study, for evaluat...
Location
Jiangsu Provincial Center for Diseases Control and Prevention